DOLBY LABORATORIES INC-CL A (DLB)

US25659T1079 - Common Stock

77.58  -0.08 (-0.1%)

After market: 77.58 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
1.281B
10.29%		1.254B
-2.15%		1.3B
3.66%		1.314B
1.10%
EBITDA
YoY % growth
436.7M
40.24%		305.7M
-30.00%		345.5M
13.02%		482.58M
39.68%
EBIT
YoY % growth
340.8M
54.56%		217.2M
-36.27%		262.9M
21.04%		337.03M
28.20%
Operating Margin
26.60%17.32%20.23%25.65%
EPS
YoY % growth
3.68
30.50%		3.15
-14.40%		3.57
13.33%		3.75
4.96%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		1.23
-2.47%
Revenue
Q2Q % growth		366.17M
-2.59%
EBITDA
Q2Q % growth		160.38M
EBIT
Q2Q % growth		124.17M
13.71%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 1.01
-9.01%		0.870.1416.28%
Q4 2023
Q2Q % growth		 0.65
20.37%		0.530.1222.19%
Q3 2023
Q2Q % growth		 0.55
-19.12%		0.56-0.01-0.99%
Q2 2023
Q2Q % growth		 1.26
36.96%		0.980.2827.95%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 315.574M
-5.77%		316M-426K-0.13%
Q4 2023
Q2Q % growth		 290.6M
4.46%		293.1M-2.5M-0.85%
Q3 2023
Q2Q % growth		 298.4M
3.04%		304.66M-6.26M-2.05%
Q2 2023
Q2Q % growth		 375.9M
12.41%		353.34M22.56M6.38%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 4.89% 0% 0.18%
Revenue0% -2.1% 0% 0.23%